Patents by Inventor Edward McDonald

Edward McDonald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8846068
    Abstract: The present invention is directed to an implantable drug depot useful for reducing, preventing or treating post-operative pain in a patient in need of such treatment, the implantable drug depot comprising a polymer and a therapeutically effective amount of a local anesthetic or pharmaceutically acceptable salt thereof, wherein the drug depot is implantable at a site beneath the skin to reduce, prevent or treat post-operative pain, and the drug depot is capable of releasing (i) a bolus dose of the local anesthetic or pharmaceutically acceptable salt thereof at a site beneath the skin and (ii) a sustained release dose of an effective amount of the local anesthetic or pharmaceutically acceptable salt thereof over a period of at least 4 days.
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: September 30, 2014
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: Amira Wohabrebbi, William F. McKay, Vanja Margareta King, Danielle L. Biggs, Katara Shaw, Christopher M. Hobot, Phillip Edward McDonald
  • Patent number: 8844347
    Abstract: An insert apparatus for installing a transducer assembly in a sensor port of a flow cell is disclosed. The transducer assembly is installed in the cavity of the insert body without the use of glues or adhesives to bond the transducer assembly to the cavity.
    Type: Grant
    Filed: February 29, 2012
    Date of Patent: September 30, 2014
    Assignee: General Electric Company
    Inventors: Lei Sui, Nicholas Joseph Mollo, Benjamin Edward McDonald, Toan Huu Nguyen, Solomon Feldman, Nicholas Anderson Hobbs, Ganesh Devkar, John Austin True, Mykhaylo Barsukov
  • Patent number: 8822546
    Abstract: Flowable pharmaceutical depots are described. The flowable pharmaceutical depot includes a polyester, such as a polylactic acid or a poly(trimethylene carbonate) endcapped with a primary alcohol and a pain relieving therapeutic agent, such as a post operative pain relieving therapeutic agent. Method of making and using the same are also described.
    Type: Grant
    Filed: December 1, 2008
    Date of Patent: September 2, 2014
    Assignee: Medtronic, Inc.
    Inventors: Michael Eric Benz, Christopher M. Hobot, Phillip Edward McDonald, Lian Leon Luo, John Kramer
  • Publication number: 20140198822
    Abstract: An apparatus and method for determining temperature is disclosed. An ultrasonic signal is generated that propagates through a buffer and a portion of the signal is reflected at an interface. A time of flight is measured between generating the ultrasonic signal and detecting the reflected portion. The temperature is determined based on the time of flight of the reflected signal.
    Type: Application
    Filed: January 14, 2013
    Publication date: July 17, 2014
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Lei Sui, Benjamin Edward McDonald, Nicholas Anderson Hobbs
  • Patent number: 8778925
    Abstract: The present invention relates to pyridine and pyrimidine based compounds, pharmaceutical compositions comprising these compounds and their potential use as therapeutic agents for the treatment and/or prevention of cancer.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: July 15, 2014
    Assignee: Cancer Research Technology Ltd.
    Inventors: Edward McDonald, Julian Blagg, Mark Pichowicz, Simon Ross Crumpler
  • Publication number: 20140103274
    Abstract: An apparatus and method for installing or removing a cable is disclosed. A cable tool includes a cable channel with two channels having different channel openings for receiving or releasing the cable. The first end of the cable channel has a smaller channel opening and an arm that can be used to remove the cable and disconnect a connector on the end of the cable from a sensor.
    Type: Application
    Filed: October 15, 2012
    Publication date: April 17, 2014
    Applicant: General Electric Company
    Inventors: Benjamin Edward McDonald, Mykhaylo Barsukov
  • Publication number: 20140094498
    Abstract: The present invention is directed to an implantable drug depot useful for reducing, preventing or treating post-operative pain in a patient in need of such treatment, the implantable drug depot comprising a therapeutically effective amount of clonidine or pharmaceutically acceptable salt thereof and a polymer; wherein the depot is implantable at a site beneath the skin to reduce, prevent or treat post-operative pain, and the depot is capable of releasing (i) about 5% to about 45% of the clonidine or pharmaceutically acceptable salt thereof relative to a total amount of the clonidine or pharmaceutically acceptable salt thereof loaded in the drug depot over a first period of up to 48 hours and (ii) about 55% to about 95% of the clonidine or pharmaceutically acceptable salt thereof relative to a total amount of the clonidine or pharmaceutically acceptable salt thereof loaded in the drug depot over a subsequent period of at least 3 days.
    Type: Application
    Filed: December 5, 2013
    Publication date: April 3, 2014
    Applicant: WARSAW ORTHOPEDIC, INC.
    Inventors: William F. McKay, Amira Wohabrebbi, Vanja Margareta King, Phillip Edward McDonald, Christopher M. Hobot, Troy Carter
  • Publication number: 20140083181
    Abstract: An apparatus configured for insertion into a sensor port of a flow cell is disclosed. The apparatus includes an insert body, a sensor located in the cavity of the insert body, and an insert body holding nut and a sensor holding nut threaded to the interior surface of the sensor port.
    Type: Application
    Filed: September 25, 2012
    Publication date: March 27, 2014
    Applicant: General Electric Company
    Inventors: Benjamin Edward McDonald, Toan Huu Nguyen, Mykhaylo Barsukov
  • Publication number: 20140043168
    Abstract: A system and method for alerting operators of mobile equipment to the presence of people in monitored areas around the periphery of the mobile equipment they are operating is provided. The system includes an RFID detection system which is installed on the mobile equipment and alerts the operator to the presence of people wearing Personal Protection Equipment containing RFID safety tags. The system also includes a tag programming system which allows RFID safety tags to be created. The system also includes a tag testing system which allows a person to test the functionality of the RFID safety tags contained in the personal safety equipment they are wearing. The system also includes RFID personal safety equipment such as 3D safety vests and RFID hardhats which contains RFID safety tags. The 3D safety vests also include enhanced 3D visual markings.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 13, 2014
    Applicant: Marlex Engineering Inc.
    Inventors: Uwe D. SCHAIBLE, Jonathan FAVA, Peter Atef Wadie BASL, Norman H. VON STYP-REKOWSKI, Jeff William Edward McDONALD, Jason Philip GARR
  • Patent number: 8629172
    Abstract: The present invention is directed to an implantable drug depot useful for reducing, preventing or treating post-operative pain in a patient in need of such treatment, the implantable drug depot comprising a therapeutically effective amount of clonidine or pharmaceutically acceptable salt thereof and a polymer; wherein the depot is implantable at a site beneath the skin to reduce, prevent or treat post-operative pain, and the depot is capable of releasing (i) about 5% to about 45% of the clonidine or pharmaceutically acceptable salt thereof relative to a total amount of the clonidine or pharmaceutically acceptable salt thereof loaded in the drug depot over a first period of up to 48 hours and (ii) about 55% to about 95% of the clonidine or pharmaceutically acceptable salt thereof relative to a total amount of the clonidine or pharmaceutically acceptable salt thereof loaded in the drug depot over a subsequent period of at least 3 days.
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: January 14, 2014
    Assignees: Warsaw Orthopedic, Inc., Medtronic, Inc.
    Inventors: William F. McKay, Amira Wohabrebbi, Vanja Margareta King, Phillip Edward McDonald, Christopher M. Hobot, Troy Carter
  • Patent number: 8621936
    Abstract: A flow cell for a plurality of sensor assemblies to communicate with a flow meter for measuring characteristics. The flow cell includes a sensor body with a sensor body bore extending through the sensor body. The flow cell also includes a sensor body quadrant extending outwardly from the sensor body bore on a side of the flow cell, wherein the sensor body quadrant intersects the sensor body bore. A plurality of sensor ports extend through the sensor body quadrant to provide openings from the exterior of the flow cell to the sensor body bore in which sensor assemblies can be inserted. A cable channel extends internally within the sensor body quadrant at least from the plurality of sensor ports to an access port on the exterior of the flow cell for routing cables from the sensor ports to communicate with the flow meter.
    Type: Grant
    Filed: October 24, 2011
    Date of Patent: January 7, 2014
    Assignee: General Electric Company
    Inventors: Benjamin Edward McDonald, Mykhaylo Barsukov
  • Patent number: 8592581
    Abstract: The present invention relates to compounds of formula (I) wherein: R1 and R2 are each independently H, alkyl or haloalkyl; R3 and R4 are each independently H, alkyl, haloalkyl or aryl; R5 is alkyl or cycloalkyl or cycloalkyl-alkyl, each of which may be optionally substituted with one or more OH groups; R6 is selected from cyclopropylamino, cyclopropylmethylamino, cyclobutylamino, cyclobutylmethylamino and where one of X, Y and Z is N and the remainder are CR9; R7, R8 and each R9 are independently H, alkyl or haloalkyl, wherein at least one of R7, R8 and each R9 is other than H. A further aspect of the invention relates to pharmaceutical compositions comprising compounds of formula (I), and the use of said compounds in treating proliferative disorders, viral disorders, stroke, alopecia, CNS disorders, neurodegenerative disorders, or diabetes.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: November 26, 2013
    Assignees: Cyclacel Limited, Cancer Research Technology Limited
    Inventors: Peter William Sheldrake, Butrus Atrash, Simon Green, Edward McDonald, Sheelagh Frame
  • Publication number: 20130289026
    Abstract: Isoxazoles of formula (A) or (B) are inhibitors of HSP90 activity, and useful for treatment of, for example cancers: wherein R1, is a group of formula (IA): —Ar1-(Alk1)p-(Z)r-(Alk2)s-Q, wherein in any compatible combination Ar1 is an optionally substituted aryl or heteroaryl radical, Alk1 and Alk2 are optionally substituted divalent C1-C6 alkylene or C2-C6 alkenylene radicals, p, r and s are independently 0 or 1, Z is -0-, —S—, —(C?O)—, —(C?S)—, —SO.sub.
    Type: Application
    Filed: June 27, 2013
    Publication date: October 31, 2013
    Inventors: Martin James Drysdale, Brian William Dymock, Harry Finch, Paul Webb, Edward McDonald, Karen Elizabeth James, Kwai Ming Cheung, Thomas Peter Matthews
  • Patent number: 8564452
    Abstract: A system and method for alerting operators of mobile equipment to the presence of people in monitored areas around the periphery of the mobile equipment they are operating is provided. The system includes an RFID detection system which is installed on the mobile equipment and alerts the operator to the presence of people wearing Personal Protection Equipment containing RFID safety tags. The system also includes a tag programming system which allows RFID safety tags to be created. The system also includes a tag testing system which allows a person to test the functionality of the RFID safety tags contained in the personal safety equipment they are wearing. The system also includes RFID personal safety equipment such as 3D safety vests and RFID hardhats which contains RFID safety tags. The 3D safety vests also include enhanced 3D visual markings.
    Type: Grant
    Filed: March 21, 2011
    Date of Patent: October 22, 2013
    Assignee: Marlex Engineering Inc.
    Inventors: Uwe D. Schaible, Jonathan Fava, Peter Atef Wadie Basl, Norman H. Von Styp-Rekowski, Jeff William Edward McDonald, Jason Philip Garr
  • Publication number: 20130219707
    Abstract: An insert apparatus for installing a transducer assembly in a sensor port of a flow cell is disclosed. The transducer assembly is installed in the cavity of the insert body without the use of glues or adhesives to bond the transducer assembly to the cavity.
    Type: Application
    Filed: February 29, 2012
    Publication date: August 29, 2013
    Applicant: General Electric Company
    Inventors: Lei Sui, Nicholas Joseph Mollo, Benjamin Edward McDonald, Toan Huu Nguyen, Solomon Feldman, Nicholas Anderson Hobbs, Ganesh Devkar, John Austin True, Mykhaylo Barsukov
  • Patent number: 8507480
    Abstract: Isoxazoles of formula (A) or (B) are inhibitors of HSP90 activity, and useful for treatment of, for example cancers: wherein R1, is a group of formula (IA): —Ar1-(Alk1)p-(Z)r-(Alk2)s-Q, wherein in any compatible combination Ar1 is an optionally substituted aryl or heteroaryl radical, Alk1 and Alk2 are optionally substituted divalent C1-C6 alkylene or C2-C6 alkenylene radicals, p, r and s are independently 0 or 1, Z is -0-, —S—, —(C?O)—, —(C?S)—, —SO.sub.
    Type: Grant
    Filed: February 19, 2010
    Date of Patent: August 13, 2013
    Assignees: Vernalis (R&D) Limited, Cancer Research Technology Limited, The Institute of Cancer Research
    Inventors: Martin James Drysdale, Brian William Dymock, Harry Finch, Paul Webb, Edward McDonald, Karen Elizabeth James, Kwai Ming Cheung, Thomas Peter Matthews
  • Patent number: 8450310
    Abstract: Isoxazoles of formula (A) or (B) wherein R1 is a group of formula (IB) The isoxazoles are inhibitors of HSP90 activity, and useful for the treatment of, for example, cancers.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: May 28, 2013
    Assignees: Vernalis (R&D) Limited, Cancer Research Technology Ltd., The Institute of Cancer Research
    Inventors: Martin James Drysdale, Brian William Dymock, Harry Finch, Paul Webb, Edward McDonald, Karen Elizabeth James, Kwai Ming Cheung, Thomas Peter Matthews
  • Publication number: 20130098167
    Abstract: A flow cell that includes a sensor body with internal cable channels for routing cables from the sensor ports to communicate with a flow meter is disclosed.
    Type: Application
    Filed: October 24, 2011
    Publication date: April 25, 2013
    Applicant: General Electric Company
    Inventors: Benjamin Edward McDonald, Mykhaylo Barsukov
  • Patent number: D689784
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: September 17, 2013
    Assignee: General Electric Company
    Inventors: Benjamin Edward McDonald, Mykhaylo Barsukov, Toan Huu Nguyen
  • Patent number: D705102
    Type: Grant
    Filed: April 17, 2013
    Date of Patent: May 20, 2014
    Assignee: General Electric Company
    Inventors: Benjamin Edward McDonald, John Albert Umina, Toan Huu Nguyen, Mykhaylo Barsukov